Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Across the recent three months, 8 analysts have shared their insights on Cigna (NYSE:CI), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 8 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 0 | 0 | 0 |
2M Ago | 0 | 2 | 0 | 0 | 0 |
3M Ago | 0 | 3 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Cigna, revealing an average target of $404.75, a high estimate of $435.00, and a low estimate of $388.00. This current average has decreased by 0.27% from the previous average price target of $405.83.
In examining recent analyst actions, we gain insights into how financial experts perceive Cigna. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Sarah James | Cantor Fitzgerald | Maintains | Overweight | $400.00 | $400.00 |
Scott Fidel | Stephens & Co. | Maintains | Overweight | $410.00 | $410.00 |
Andrew Mok | Barclays | Raises | Overweight | $405.00 | $393.00 |
Sarah James | Cantor Fitzgerald | Maintains | Overweight | $400.00 | $400.00 |
Jessica Tassan | Piper Sandler | Announces | Overweight | $400.00 | - |
Sarah James | Cantor Fitzgerald | Maintains | Overweight | $400.00 | $400.00 |
Lisa Gill | JP Morgan | Raises | Overweight | $435.00 | $432.00 |
Michael Ha | Baird | Announces | Outperform | $388.00 | - |
To gain a panoramic view of Cigna's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Cigna analyst ratings.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Cigna's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 24.4%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Cigna's net margin is impressive, surpassing industry averages. With a net margin of 2.56%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Cigna's ROE stands out, surpassing industry averages. With an impressive ROE of 3.75%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cigna's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.0% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.77, Cigna adopts a prudent financial strategy, indicating a balanced approach to debt management.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CI